Loading data for XBI — first visit, this takes a few seconds.
State Street SPDR S&P Biotech ETF (XBI)
NYSEArca: XBI
· 即時價格 · USD
156.20
-0.62 (-0.40%)
收盤價： Sep 11, 2026, 3:59 PM
156.43
+0.15%
盤後: 7:02 PM
State Street SPDR S&P Biotech ETF（XBI）ETF 價格、持股與分析
| 買價 | 156.16 |
| 市值 | 不適用 |
| AUM | 11.4B |
| 資產淨值 | 156.87 |
| 貝他值 | 1.12 |
| EPS (ttm) | 不適用 |
| 本益比（ttm） | 不適用 |
| 分享出去 | 不適用 |
| 成立日期 | Jan 31, 2006 |
| 賣價 | 156.22 |
| 成交量 | 8,411,294 |
| 20 日平均成交量 | 8,840,152 |
| 開盤價 | 158.27 |
| 前收盤價 | 156.82 |
| 當日區間 | 156.13 - 159.66 |
| 52 週範圍 | 92.64 - 169.89 |
| 持股 | 不適用 |
| 總費用率 | 0.35% |
關於 XBI
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
十大持股 15.64 資產%
| 名稱 | 代號 | 重量 |
|---|---|---|
| Moderna Inc | MRNA | 2.81% |
| Twist Bioscience Cor... | TWST | 1.89% |
| Apogee Therapeutics ... | APGE | 1.5% |
| Kymera Therapeutics ... | KYMR | 1.4% |
| Halozyme Therapeutic... | HALO | 1.39% |
| Natera Inc | NTRA | 1.37% |
| Praxis Precision Med... | PRAX | 1.34% |
| Oruka Therapeutics I... | ORKA | 1.33% |
| Revolution Medicines... | RVMD | 1.31% |
| Travere Therapeutics... | TVTX | 1.3% |
股利 股利殖利率 0.37%
| 前股利 | 金額 | 付款日期 |
|---|---|---|
| Jun 22, 2026 | $0.1380 | 不適用 |
| Dec 22, 2025 | $0.4070 | 不適用 |
| Sep 22, 2025 | $0.0270 | 不適用 |
| Jun 23, 2025 | $0.0070 | 不適用 |
| Mar 24, 2025 | $0.0050 | 不適用 |
2 週前 · Investor's Business Daily
Analysts See Drastic Change For This Particular Part Of HealthcareThe biotech fund is one of two ETFs in IBD Leaderboard. The S&P 500 Biotech index gapped up to nearly an all-time high last Wednesday, a bullish day for the industry. While Moderna shares have remai...
第 1 頁，共 2 頁